BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 25978692)

  • 1. The Significance of Neuregulin-1/ErbB Expression in Autogenous Vein Grafts in a Diabetic Rat Model.
    Huang Q; Zhang J; Liang L; Lan Z; Huo T; Li S
    J Cardiovasc Pharmacol; 2015 Sep; 66(3):300-6. PubMed ID: 25978692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Type 1 diabetes mellitus abrogates compensatory augmentation of myocardial neuregulin-1β/ErbB in response to myocardial infarction resulting in worsening heart failure.
    Odiete O; Konik EA; Sawyer DB; Hill MF
    Cardiovasc Diabetol; 2013 Mar; 12():52. PubMed ID: 23530877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuregulin-1 attenuates neointimal formation following vascular injury and inhibits the proliferation of vascular smooth muscle cells.
    Clement CM; Thomas LK; Mou Y; Croslan DR; Gibbons GH; Ford BD
    J Vasc Res; 2007; 44(4):303-12. PubMed ID: 17438359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of RAGE in aminoguanidine-induced suppression of venous intimal hyperplasia in diabetic rats.
    Wang X; Diao Y; Zhang H; Huo X; Zhang Q
    Ann Vasc Surg; 2009 Mar; 23(2):246-54. PubMed ID: 19110400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of tissue factor protein expression in experimental venous bypass grafts.
    Channon KM; Fulton GJ; Davies MG; Peters KG; Ezekowitz MD; Hagen PO; Annex BH
    Arterioscler Thromb Vasc Biol; 1997 Jul; 17(7):1313-9. PubMed ID: 9261261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The Role of Bone Morphogenic Protein-4 in the Progression of Vein Graft Hyperplastic Remodeling under Hyperglycemic Condition].
    Fang DF; Zhang HW; Gu J; Fan KJ; Liang HM; Shen JY; Zhang EY; Hu J
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2017 Sep; 48(5):710-715. PubMed ID: 29130662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuregulin-1 attenuates stress-induced vascular senescence.
    Shakeri H; Gevaert AB; Schrijvers DM; De Meyer GRY; De Keulenaer GW; Guns PDF; Lemmens K; Segers VF
    Cardiovasc Res; 2018 Jun; 114(7):1041-1051. PubMed ID: 29528383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vein graft arterialization causes differential activation of mitogen-activated protein kinases.
    Saunders PC; Pintucci G; Bizekis CS; Sharony R; Hyman KM; Saponara F; Baumann FG; Grossi EA; Colvin SB; Mignatti P; Galloway AC
    J Thorac Cardiovasc Surg; 2004 May; 127(5):1276-84. PubMed ID: 15115983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced superoxide production in experimental venous bypass graft intimal hyperplasia: role of NAD(P)H oxidase.
    West N; Guzik T; Black E; Channon K
    Arterioscler Thromb Vasc Biol; 2001 Feb; 21(2):189-94. PubMed ID: 11156851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Celiprolol reduces the intimal thickening of autogenous vein grafts via an enhancement of nitric oxide function through an inhibition of superoxide production.
    Hattori K; Yamanouchi D; Banno H; Kobayashi M; Yamamoto K; Kajikuri J; Itoh T; Komori K
    J Vasc Surg; 2007 Jul; 46(1):116-23. PubMed ID: 17606127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydrophilic statin suppresses vein graft intimal hyperplasia via endothelial cell-tropic Rho-kinase inhibition.
    Yamanouchi D; Banno H; Nakayama M; Sugimoto M; Fujita H; Kobayashi M; Kuwano H; Komori K
    J Vasc Surg; 2005 Oct; 42(4):757-64. PubMed ID: 16242565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postprocedure administration of insulin in canine autologous vein grafting: a potential strategy to attenuate intimal hyperplasia.
    Zhou N; Yu QJ; Si R; Gao HK; Wang T; Gao F; Wang HC; Bian JF
    J Cardiovasc Pharmacol; 2010 Oct; 56(4):402-12. PubMed ID: 20625311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The expression and function of G-proteins in experimental intimal hyperplasia.
    Davies MG; Ramkumar V; Gettys TW; Hagen PO
    J Clin Invest; 1994 Oct; 94(4):1680-9. PubMed ID: 7929847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuregulin-1 Promotes Myocardial Angiogenesis in the Rat Model of Diabetic Cardiomyopathy.
    Gui C; Zeng ZY; Chen Q; Luo YW; Li L; Chen LL
    Cell Physiol Biochem; 2018; 46(6):2325-2334. PubMed ID: 29742506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuregulin-1/ErbB signaling is impaired in the rat model of diabetic cardiomyopathy.
    Gui C; Zhu L; Hu M; Lei L; Long Q
    Cardiovasc Pathol; 2012; 21(5):414-20. PubMed ID: 22285193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blockade of monocyte chemoattractant protein-1 by adenoviral gene transfer inhibits experimental vein graft neointimal formation.
    Tatewaki H; Egashira K; Kimura S; Nishida T; Morita S; Tominaga R
    J Vasc Surg; 2007 Jun; 45(6):1236-43. PubMed ID: 17543688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sarpogrelate hydrochloride reduced intimal hyperplasia in experimental rabbit vein graft.
    Kodama A; Komori K; Hattori K; Yamanouchi D; Kajikuri J; Itoh T
    J Vasc Surg; 2009 May; 49(5):1272-81. PubMed ID: 19233592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral monoterpene therapy (perillyl alcohol) reduces vein graft intimal hyperplasia.
    Fulton GJ; Barber L; Svendsen E; Hagen PO; Davies MG
    J Surg Res; 1997 Apr; 69(1):128-34. PubMed ID: 9202658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perivascular delivery of a nitric oxide donor inhibits neointimal hyperplasia in vein grafts implanted in the arterial circulation.
    Chaux A; Ruan XM; Fishbein MC; Ouyang Y; Kaul S; Pass JA; Matloff JM
    J Thorac Cardiovasc Surg; 1998 Mar; 115(3):604-12; discussion 612-4. PubMed ID: 9535448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-365 promotes the contractile phenotype of venous smooth muscle cells and inhibits neointimal formation in rat vein grafts.
    Cao BJ; Zhu L; Wang XW; Zou RJ; Lu ZQ
    IUBMB Life; 2019 Jul; 71(7):908-916. PubMed ID: 30746857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.